CHIP amplifies the risk of lymphoid malignancies in individuals with monoclonal B-cell lymphocytosis (MBL)

Abstract Monoclonal B-cell lymphocytosis (MBL) and clonal hematopoiesis of indeterminate potential (CHIP) are prevalent clonal precursors associated with increased risk of lymphoid malignancies. However, the relationship between MBL and CHIP and their combined impact on lymphoid malignancy risk rema...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Nicholas J. Boddicker, Tait D. Shanafelt, Sameer A. Parikh, Kari G. Rabe, Rosalie Griffin, Aaron D. Norman, Yuan Yao, Shulan Tian, Tao Ma, Daniel R. O’Brien, Bryan A. Vallejo, Mingma S. Hoel, Stacey J. Lehman, Janet E. Olson, Paul J. Hampel, Esteban Braggio, Mrinal M. Patnaik, James R. Cerhan, Celine M. Vachon, Curtis A. Hanson, Susan L. Slager
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Publishing Group 2025-11-01
coleção:	Blood Cancer Journal
Acesso em linha:	https://doi.org/10.1038/s41408-025-01385-8
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!